Francesco Costa

Francesco Costa

Interventional cardiologist / Cardiologist
Hospital Universitario Virgen de la Victoria - Malaga, Spain

Member of the Editorial Team, PCRonline Editorial Board

Declaration of interest

FunctionCompany
None

Latest contributions

Can’t stand heavy metal: how to treat an ACS with severe metal allergy?

17 Mar 2025

Francesco Costa

Author

Francesco Costa

Author

Antonio Muñoz Garcia
Alberto Piserra

Author

Alberto Piserra

Author

Juan Horacio Alonso Briales

No go (again) for oral anticoagulation after TAVR: Results of the ADAPT-TAVR trial

04 Apr 2022

Francesco Costa analyses the results of ADAPT-TAVR, a prospective randomized trial on edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement.

Francesco Costa

Author

Francesco Costa

PCRonline @ ACC 2022 Scientific Sessions

29 Mar 2022

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.

SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

04 Nov 2021

The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.

Francesco Costa

Author

Francesco Costa

PCRonline @ TCT 2021 - Get the international perspective!

03 Nov 2021

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!

PCRonline @ TCT Connect 2020

25 Sep 2020

View reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 online edition of TCT Connect. Check out the list here!

REALITY - A trial of transfusion strategies for myocardial infarction and anemia

03 Sep 2020

ESC Congress 2020: Tabassome Simon (Paris, France) discusses with Francesco Costa the results of REALITY trial which supports the use of a restrictive strategy for blood transfusion in MI patients with anemia.

Francesco Costa

Author

Francesco Costa

PCRonline @ ESC Congress 2020: the digital experience

25 Aug 2020

Make sure you stay up to date with what's new and hot in interventional cardiology.

Impella vs. balloon pump, COLCOT, RECOVERY… reported from AHA 2019 in Philadelphia

19 Nov 2019

Mirvat Al Asnag and Francesco Costa present a brief overview of Impella vs. balloon pump, COLCOT, and RECOVERY trials presented at the AHA 2019 in Philadelphia...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Francesco Costa

Author

Francesco Costa

Results for the ISCHEMIA trials: To intervene or not to intervene?

19 Nov 2019

At AHA 2019 in Philadelphia - USA, Judith S Hochman presented the results of the ISCHEMIA trial. Mirvat Al Asnag interviews David J Maron and Francesco Costa interviews Gregg W. Stone about the primary results of these trials.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Francesco Costa

Author

Francesco Costa

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based antithrombotic regimen following successful coronary stenting in atrial fibrillation patients

09 Sep 2019

Francesco Costa, Italy, interviews Pascal Vranckx, PI of the ENTRUST-AF-PCI Trial

ISAR REACT 5 - Ticagrelor versus prasugrel in patients with acute coronary syndrome

03 Sep 2019

At the ESC Congress 2019 in Paris, Stefanie Schuepke presented the results of the ISAR REACT 5 study. Read this analysis by Francesco Costa and view a short interview with Stefanie Schuepke.

Francesco Costa

Author

Francesco Costa

PCR @ ESC Congress 2019 and the World Congress of Cardiology: the interventional cardiology perspective!

19 Jul 2019

What was new and hot in interventional cardiology at ESC Congress 2019!

ACC 2019 Day 2: primary results of the AUGUSTUS trial, Ticagrelor vs DAPT and more

19 Mar 2019

Francesco Costa reports live on late-breaking trials of interest for the interventional community presented at ACC 2019: AUGUSTUS, GLASSY, TICAGRELOR REVERSAL, DEFINE PCI and MRUSMI.

Francesco Costa

Author

Francesco Costa

PCR @ ACC 2019 Scientific Sessions

13 Mar 2019

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2019 Scientific Sessions #ACC19.